INS and gestational diabetes: The package insert now reads: “if clinically indicated, the use of metformin during pregnancy and in the periconceptional period can be considered in addition to or as an alternative to insulin” (agenziafarmaco.gov.it; last accessed: 29 July 2023); thereby leaving an opening for the use of metformin in GDM.